DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
MD logo

Pediatrix Medical Group, Inc. Stock Price

NYSE:MD Community·US$2.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 10 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

MD Share Price Performance

US$25.93
9.66 (59.37%)
​
US$26.33
Fair Value
US$25.93
9.66 (59.37%)
1.5% undervalued intrinsic discount
US$26.33
Fair Value
Price US$25.93
AnalystConsensusTarget US$26.33
AnalystLowTarget US$21.00
AnalystHighTarget US$27.00
Thu, 20 Aug 26
Fair ValueUS$26.33
Share Pricen/a

MD Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$26.33 1.5% undervalued intrinsic discount

MD: Share Repurchase Plan And Margin Gains Will Support Future Performance

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$21 23.5% overvalued intrinsic discount

Rising Reimbursement Risks And Labor Shortages Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$27 4.0% undervalued intrinsic discount

US Pediatric Growth And Telehealth Expansion Will Elevate NICU Care

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
MD logo
Pediatrix Medical Group
1.5% undervalued intrinsic discount

MD: Share Repurchase Plan And Margin Gains Will Support Future Performance

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 20 Aug
Read Narrative
MD logo
Pediatrix Medical Group
23.5% overvalued intrinsic discount

Rising Reimbursement Risks And Labor Shortages Will Erode Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 6 Aug
Read Narrative
MD logo
Pediatrix Medical Group
4.0% undervalued intrinsic discount

US Pediatric Growth And Telehealth Expansion Will Elevate NICU Care

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 4 May
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystConsensusTarget
MD logo

MD: Rich Multiple And Softer Margins Will Shape Post Selloff Buyback Benefits

Fair Value: US$26.33 1.5% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
MD logo

MD: Strong Results And Index Additions Will Still Face Hospital Fee Headwinds

Fair Value: US$21 23.5% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
MD logo

MD: Future Returns Will Rely On Tennessee Expansion That Supports Buybacks

Fair Value: US$27 4.0% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Undervalued with solid track record.

0 Risks
3 Rewards
View Full Analysis

Pediatrix Medical Group, Inc. Key Details

US$2.0b

Revenue

US$1.4b

Cost of Revenue

US$511.8m

Gross Profit

US$337.0m

Other Expenses

US$174.8m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
2.20
26.24%
8.96%
66.3%
View Full Analysis

About MD

Founded
1979
Employees
4280
CEO
Mark Ordan
WebsiteView website
www.pediatrix.com

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Recent MD News & Updates

User avatar
Narrative Update • Aug 20

MD: Rich Multiple And Softer Margins Will Shape Post Selloff Buyback Benefits

Analysts have adjusted their price target for Pediatrix Medical Group from $23.17 to $26.33, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E levels. What’s in the News for Pediatrix Medical Group Pediatrix Medical Group reported Q2 2026 revenue that was 4% higher year over year, with non GAAP earnings per share 6.6% above analyst estimates, according to recent earnings coverage.
User avatar
Narrative Update • Aug 06

MD: Strong Results And Index Additions Will Still Face Hospital Fee Headwinds

Analysts have lifted their price target on Pediatrix Medical Group from $19.00 to $21.00, citing updated assumptions for slightly lower revenue growth, a modestly higher profit margin, a small change in discount rate, and an adjusted future P/E multiple. What’s in the News for Pediatrix Medical Group Pediatrix Medical Group reported second quarter results that management described as strong, with performance linked to recent acquisitions and same unit reimbursement metrics.

Recent updates

No updates

Pediatrix Medical Group, Inc. Competitors

BAX logo

Baxter International

Symbol: NYSE:BAX
Market cap: US$11.9b
BTSG logo

BrightSpring Health Services

Symbol: NasdaqGS:BTSG
Market cap: US$11.8b
DVA logo

DaVita

Symbol: NYSE:DVA
Market cap: US$11.7b
MOH logo

Molina Healthcare

Symbol: NYSE:MOH
Market cap: US$10.7b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide